CTVA - Corteva, Inc.

NYSE - NYSE Delayed Price. Currency in USD
30.24
+1.82 (+6.40%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close28.42
Open28.69
Bid28.08 x 1400
Ask31.33 x 900
Day's Range28.56 - 30.31
52 Week Range24.35 - 32.78
Volume4,285,068
Avg. Volume6,661,761
Market Cap22.647B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.41
Earnings DateN/A
Forward Dividend & Yield0.52 (1.83%)
Ex-Dividend Date2019-07-30
1y Target Est33.10
Trade prices are not sourced from all markets
  • After the DowDuPont Split: An Investor’s Guide to the 3 New Companies
    Motley Fool

    After the DowDuPont Split: An Investor’s Guide to the 3 New Companies

    The chemical industry heavyweight is gone, and DuPont and Dow are officially back -- but very different. Here's how to keep track of the new companies.

  • Reuters

    REFILE-Corteva forecasts higher revenue growth for 2020 and beyond

    Corteva Inc on Thursday raised its revenue growth forecast for 2020 and beyond to a range of 4% to 6%, citing expectations of higher pesticide sales. The company, which had earlier forecast overall revenue growth of 3% to 5%, also raised its revenue growth forecast for its crop protection business to a range of 5% to 7% from a range of 3.5% to 6.5%.

  • PR Newswire

    Corteva Affirms 2019 Guidance and Updates Mid-Term Financial Targets on CFO Webcast

    WILMINGTON, Del., Aug. 15, 2019 /PRNewswire/ -- Corteva, Inc. (CTVA) will host a webcast today with investors and industry analysts to share supplemental information on 2019 financial guidance issued on August 1, as well as updates to mid-term financial targets, and perspective on valuation and cash flows. The webcast will be led by Greg Friedman, Executive Vice President and Chief Financial Officer for Corteva. "In building Corteva, we have remained consistent in our commitment to drive sustainable shareholder value by focusing on the execution of levers in our control.

  • GuruFocus.com

    Quaker Capital Investments, LLC Buys Range Resources Corp, Corteva Inc, Sells T-Mobile US Inc, ...

    Canonsburg, PA, based Investment company Quaker Capital Investments, LLC (Current Portfolio) buys Range Resources Corp, Corteva Inc, sells T-Mobile US Inc, DuPont de Nemours Inc, Reed's Inc, DISH Network Corp during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Quaker Capital Investments, LLC. Continue reading...

  • PR Newswire

    Corteva Agriscience Chief Financial Officer Hosts Webcast

    WILMINGTON, Del., Aug. 13, 2019 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced that it will host a webcast on Thursday, August 15 at 8 a.m. ET. Greg Friedman, Executive Vice President and Chief Financial Officer, will provide supplemental information on the 2019 financial guidance previously provided on August 1 – and on the Company's mid-term financial targets. Following his presentation remarks, Friedman will be joined by Corteva Chief Executive Officer, James C. Collins, Jr., for a moderated Q&A session.

  • Barrons.com

    Five Winners, Five Losers as Earnings Season Wraps Up

    With the second-quarter earnings season in its final stretch, some clear winners and losers have emerged. The five best-performing stocks since the season began around July 19 are (SHW), (TWTR), (CTVA), (NOC), and (TDG) All five beat Wall Street expectations. For Twitter and Corteva, an agricultural chemical company, the rally represents relief.

  • Barrons.com

    Corteva Stock Gets Upgraded Because the Weather Is So Bad It’s Good

    RBC upgraded shares of two agricultural input providers—Corteva and FMC—to Buy because the weather is so bad in the U.S. it means more demand from farmers down the road.

  • PR Newswire

    Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies

    YANGON, Myanmar, Aug. 7, 2019 /PRNewswire/ -- Pure-play global agriculture leader, Corteva Agriscience (NYSE:CTVA), has officially launched its brand in Myanmar. In conjunction with the brand launch, the company also introduced Zorvec® Encantia® fungicide - a new international award-winning disease control product with a favourable environmental profile - to Myanmar's vegetable farmers. Corteva represents the combined strengths of DuPont Crop Protection, Pioneer and Dow AgroSciences, which listed on the New York Stock Exchange on June 1, 2019, creating a market-shaping, standalone, pure-play agriculture company with leading positions in Seed Technologies, Crop Protection and Digital Agriculture.

  • TheStreet.com

    Ex-DowDuPont Unit Corteva Jumps as Adjusted Profit Exceeds Estimates

    Corteva shares jumped 5.9% to $31.25 on Thursday even as it reported quarterly profit was more than halved due to costs related to the DowDuPont breakup. The Wilmington, Del., company, formerly the agricultural unit of DowDuPont, reported second-quarter net income fell to $470 million, or 63 cents a share, from $963 million, or $1.

  • Reuters

    UPDATE 2-Corteva shares rise as profit beats on international markets

    Pesticide and insecticide maker Corteva Inc's quarterly profit beat estimates as volumes and prices in its international markets rose more than expected, sending its shares up more than 8%. Investors cheered Corteva's upbeat numbers, its first after separation from DowDupont in June, as they were a rare bright spot among agricultural companies that have been hard hit as floods ravaged huge swathes of western Corn Belt states. Chief Executive James Collins, on a post-earnings call with analysts, said the unprecedented market backdrop for the second quarter presented considerable challenges to Corteva's customers and in turn, to the company.

  • PR Newswire

    Corteva Agriscience Reports Second Quarter 2019 Operating Results - Capitalizes on Strong Performance Outside North America; Company Updates Full Year Outlook

    - GAAP earnings per share (EPS) from continuing operations was $0.63 , with operating EPS¹ of $1.42 . - The Company delivered net sales of $5.6 billion , down 3 percent versus the same quarter last year, ...

  • Barrons.com

    Sizing Up an Environmental Liability for 3M and Others

    PFAS, short for per- and polyfluoroalkyl substances, are a group of chemicals, manufactured in the U.S. from the 1940s through roughly the turn of the century, that can harm people’s health, according to the Environmental Protection Agency. States and municipalities are cleaning up sites involved in the manufacture of the chemicals, while governments are pursuing liability suits seeking money from producers. In the first quarter of 2019, 3M (ticker: MMM) took a $548 million charge for litigation, which it said included $235 million for lawsuits related to PFAS.

  • Corteva Has Formed an Equilateral Triangle - Look for a Breakout
    TheStreet.com

    Corteva Has Formed an Equilateral Triangle - Look for a Breakout

    In his "No-Huddle Offense" segment of Mad Money Tuesday night, Jim Cramer weighed in on Corteva, Inc. , the recent spinoff from DowDuPont . Cramer said there's a lot to like about Corteva. Cramer noted that the combination of bumper crops last year, a trade war this year and flooding in the Midwest, is creating a tough time for farmers and Corteva isn't expected to see great earnings until 2020.

  • T. Rowe Price Buys Fox, General Electric
    GuruFocus.com

    T. Rowe Price Buys Fox, General Electric

    Firm's largest buys of 2nd quarter Continue reading...

  • PR Newswire

    Corteva Agriscience CEO James C. Collins Provides Testimony to U.S. Senate Finance Committee in Support of the United States-Mexico-Canada Trade Agreement (USMCA)

    As a Partner to the American Farming Community, Collins Made Clear the Need for Strong Trade Agreements to Support One of the Nation's Most Important Economic Engines WILMINGTON, Del. , July 30, 2019 /PRNewswire/ ...

  • Barrons.com

    Here’s What’s Wrong With DowDuPont Spinoffs Dow, DuPont, and Corteva

    Wall Street is souring on the new Dow, one of the stand-alone companies that once were part of the chemical giant DowDuPont. Investors aren’t too hot on any of the three.

  • What Awaits Corteva (CTVA) in its Debut Q2 Earnings Report?
    Zacks

    What Awaits Corteva (CTVA) in its Debut Q2 Earnings Report?

    Digital efforts and product innovation are likely to benefit Corteva's (CVTA) second-quarter 2019 results. Further, it will gain from momentum in the seeds market.

  • Buy Dow Stock for the Dividend as the Breakup Dust Settles
    InvestorPlace

    Buy Dow Stock for the Dividend as the Breakup Dust Settles

    After several years of planning, negotiations, talking with regulators, and other such work, the great DowDuPont (Dow ((NYSE:DOW)), DuPont ((NYSE:DD)) merger and subsequent breakup is complete. The old Dow Chemical and DuPont merged awhile ago with the explicit intention to break back up afterward. Why'd they do this? And what's it mean for the new DOW stock? Click to Enlarge Source: Shutterstock The strategic rationale is a solid one. Both Dow and DuPont had a lot of businesses and product lines that competed directly with each other. The firms were fierce rivals, in fact.By bringing everything together in one company, Dow and DuPont could stop needlessly competing with each other. However, the combined firm was an absolute industrial behemoth. To keep things manageable, the companies decided to split the united organization up into three standalone entities.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Buy From This Superstar Fund With the completed spin-off of Corteva (NYSE:CTVA) earlier this spring, the long M&A process is finally over. DowDupont has now fully demerged into three entities: Dow, Dupont and Corteva. Dow is the commodity chemical business, with a general focus on products made out of hydrocarbons. DuPont makes a wide variety of chemicals that go into a large number of industrial applications. Corteva is the smallest firm of the three and focuses exclusively on agricultural seeds and chemicals. DuPont and Corteva Offer More GrowthOf the three firms, Corteva should offer investors the most growth prospects. Its seeds business, in particular, is a strong one. It has only a few rivals, namely Monsanto and Syngenta. Both of those firms produced massive shareholder returns in recent decades before being acquired. Farmers rely on the trio of those two, plus Corteva, for cutting-edge seeds that boost agricultural production and help resist pests and drought among other maladies.Corteva's agricultural chemicals are also designed, in large part, to work in combination with its GMO seeds. Both Dow and DuPont had a strong business in agriculture, so the combined firm should be a winner. I added to my CTVA stock position after the spin-off concluded.DuPont is another interesting option out of the three. Post-M&A activity, DuPont is now exposed to a vast number of businesses. These range from kitchen plastic wrap to Kevlar vests, micro-components for automotive electronics and a long list of other such things. DuPont gets no more than 15% of its revenues from any one industry.This gives it wide diversification and protects it from a recession more than most other industrial firms. DD stock should offer folks a strong growth and income combination, though its starting 2% dividend yield isn't massive. The Best Option for Dividend InvestorsWhile DuPont and Corteva offer attractive growth, the main appeal for DOW stock is its generous dividend policy. DOW stock offers a 70 cent per quarter payout. That's $2.80 per year, or a nearly 5.5% dividend yield at the current Dow stock price.Based on current earnings projections, Dow can cover that payout from its earnings though it is certainly an aggressive payout. Over time, Dow should be able to grow its earnings, as it has cut nearly $1.4 billion in costs as a result of merger synergies. It expects to pick up several hundred million more in additional savings.Over time, Dow plans to return 65% of its cash flow to investors, with around 45% of that coming in the form of dividends. The rest will be devoted to DOW stock buybacks.This strategy makes a lot of sense. Dow is, generally, in a lot of slow-growing or mature businesses. It doesn't need to invest much in R&D as a result, unlike, say, Corteva with its next-gen agricultural seeds. So the new Dow is an ideal vehicle for income-focused investors. Dow Stock VerdictThat said, it's not all roses and sunshine for investors in the Dow Chemical. A lot of Dow's businesses are pretty stagnant. And a good number rely on oil as an input and are subject to margin pressures depending on commodity prices. As it is, analysts see Dow's revenues actually falling a bit in 2019 before leveling off in 2020 and 2021. The earnings growth, to the extent it comes, will be from cost savings. The share buyback should also raise EPS once it starts taking effect.There's a lot to like about Dow Inc's stock post-breakup if you are an income investor. The stock already yields 5.5%, which puts it at nearly triple the S&P 500's yield or that of 10-year treasury bonds.If Dow management is able to follow through on projected cost savings, it should be able to hike the dividend dramatically over the next two years. If management hits its projections, DOW stock's yield could reach 7% within a couple of years.Don't expect DOW stock to skyrocket anytime soon, however. Competitors like LyondellBasell Industries (NYSE:LYB) and Westlake Chemical (NYSE:WLK) trade at around 8x earnings.So Dow, at 9x, is actually slightly more expensive than its immediate peers. The dividend is great, but investors simply aren't going to value a stodgy low-growth chemical business very highly. And earnings - and the dividend - could get hit the next time a recession rolls around.At the time of this writing, Ian Bezek owned DOW, DD, and CTVA stock. You can reach him on Twitter at @irbezek. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy From This Superstar Fund * 7 Stocks to Buy This Summer Earnings Season * 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk The post Buy Dow Stock for the Dividend as the Breakup Dust Settles appeared first on InvestorPlace.

  • GuruFocus.com

    The Top 5 Buys of the T Rowe Price Equity Income Fund

    Fund releases 2nd-quarter portfolio Continue reading...

  • Dow Stock Is a Misjudged, Undervalued Dividend Play Worth a Shot
    InvestorPlace

    Dow Stock Is a Misjudged, Undervalued Dividend Play Worth a Shot

    Owners of chemical giant Dow Inc (NYSE:DOW) expecting the recent three-way split to immediately "unlock value" are likely to be disappointed. DOW stock is down -- again -- since its late-March separation from parent company DuPont de Nemours (NYSE:DD) and fellow spinoff sibling Corteva (NYSE:CTVA). Even more worrisome, the technical chart suggests more pain to follow.Source: Roy Luck via Flickr (modified)However, you may want to catch this falling knife for a few reasons.First, we don't know much about the true fundamentals driving Dow Inc stock. Thus, current investors are somewhat acting on blind faith. The other reason? Chemical stocks have performed relatively poorly. Therefore, mere association keeps a lid on DOW.InvestorPlace - Stock Market News, Stock Advice & Trading TipsDon't let either impasse deter you though. Following the HerdIt was a curious if not confusing saga. Dow and DuPont completed their merger in 2017, but with the ultimate intent of splitting into the three companies. For management to implement greater fiscal efficiencies and more effective groupings, they consolidated the various pieces and acquisitions. * The 7 Top Small-Cap Stocks Of 2019 With the improvements and restructuring finally falling into place last year, management spun off DOW in March. Shares of Dow Inc stock began trading independently on March 20th. Agricultural chemical outfit Corteva became a fully independent company with its own stock on May 24th.Investors weren't particularly kind to either name, initially. They've also been notably wary of DuPont, superficially suggesting the split may have been a mistake. Some value exists in levering expertise in a specific area. But perhaps in this instance it wasn't necessary.Or, the market was simply dragging all three names lower.That is largely what happened, by the way. The S&P 500 rolled over in early May, accelerating the selloff Dow stock was already working on. Chemicals as a group fared no better. The market-wide (and industry-wide) tide also lifted DOW in early June; Corteva shares finally caught up in the latter half of June. Click to EnlargeNone of the early weaknesses properly represents their true fundamental value. Instead, mere technical factors drove them down. Hidden ValueThat said, it's difficult to blame investors for letting Dow Inc stock roll with the tide. While the spinoff was completed in March, critical fundamental data about Dow remains elusive.However, elusive doesn't mean that it's impossible to obtain. Thomson Reuters can supply it to those who are willing to dig. And what various analysts have dug up so far is compelling. Namely, experts predict Dow -- the new and improved standalone Dow -- to remain profitable, and grow. Click to EnlargeValue exists here too. The expected earnings of $4.37 per share this year translates into a price-earnings ratio of 11.5. Next year's projected bottom line of $5.28 per share of DOW stock becomes a price-earnings of 9.5.Those profit projections leave plenty of room for dividends too, which Dow has already been readily willing to pay. It dished out 70 cents worth of per-share dividend in June. Annualizing that figure to $2.80 is still only a little over half the company's likely income. It also represents an above-average yield of 5.6% for investors that step into a position at today's prices.Investors are struggling to see it though, mostly because there's no recorded history for this particular version of Dow Inc. Looking Ahead for Dow StockAdmittedly, it's not a black-and-white matter. While the average retail investor may not see it, the institutional investors are likely at least moderately aware of the reliable growth narrative here. After all, they largely control the market, and individual stock prices. The smart-money crowd clearly didn't keep Dow stock propped up against the market's bearish tide when they arguably should have.That's still a rather tall order just three months out from the spinoff though. Even the professionals are still struggling to gather and digest all the relevant data. At the same time, they're adjusting their guesses to reflect the impact of the U.S.-China tariff war.As time passes and the fog lifts though, look for the value play for Dow stock to conspicuously emerge.As of this writing, James Brumley held no position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 7 Top Small-Cap Stocks Of 2019 * Critical Levels to Watch in 7 Marijuana Stocks * 5 Smaller Cloud Stocks That Have Plenty of Potential Compare Brokers The post Dow Stock Is a Misjudged, Undervalued Dividend Play Worth a Shot appeared first on InvestorPlace.

  • DuPont and Corteva Statement on The Chemours Company Lawsuit
    PR Newswire

    DuPont and Corteva Statement on The Chemours Company Lawsuit

    Further, the obligations assumed by Chemours generally arise from the very businesses that are a part of Chemours today. Based on Chemours' public statements, we believe Chemours has been a successful company since its spinoff in July 2015.

  • MoneyShow

    Corteva- Spin-Off in Seeds and Crop Protection

    Corteva (CTVA) is a new publicly traded company, having been spun off from DowDuPont (DWDP) on June 1, observes Chuck Carlson, dividend reinvestment specialist and editor of DRIP Investor.

  • Benzinga

    Corteva Trades Higher After Announcing Buyback, Dividend

    Corteva Inc (NYSE: CTVA ) shares are trading higher after the company announced a $1 billion stock buyback and declared its first dividend of 13 cents per share. Corteva is an agricultural chemical and ...

  • CNW Group

    Corteva Announces $1 Billion Share Repurchase Program and Quarterly Dividend

    WILMINGTON, Del. , June 26, 2019 /CNW/ -- Corteva, Inc. (NYSE: CTVA) today announced the authorization of a $1 billion share repurchase program and first common stock dividend after its spinoff from DowDuPont – collectively reinforcing the Company's ongoing commitment to return value to shareholders. The Company's Board of Directors authorized a $1 billion share repurchase program.  The program is expected to be completed in three years.